Skip to main content

Peer Review reports

From: CDK4/6 inhibitors plus endocrine therapy vs. placebo plus endocrine therapy for HR+/HER2- advanced breast cancer: a phase III RCTs based meta-analysis

Original Submission
24 Apr 2024 Submitted Original manuscript
24 May 2024 Reviewed Reviewer Report
30 May 2024 Reviewed Reviewer Report - Luca Moscetti
24 Jun 2024 Author responded Author comments - Zhongkui Jin
Resubmission - Version 2
24 Jun 2024 Submitted Manuscript version 2
1 Jul 2024 Reviewed Reviewer Report - Luca Moscetti
6 Aug 2024 Author responded Author comments - Zhongkui Jin
Resubmission - Version 3
6 Aug 2024 Submitted Manuscript version 3
Publishing
8 Aug 2024 Editorially accepted
21 Aug 2024 Article published 10.1186/s12885-024-12782-w

You can find further information about peer review here.

Back to article page